| Size & multiples | |||
| Market Cap | €91.1M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 0.02× | P/FCF | 0.20× |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | 497.23% | Buyback Yield | 19.97% |
| Owner Earnings (TTM) | €500.6M | Owner Earnings Yield | 549.35% |
| Shareholder Yield | 136.41% | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.53 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 6.63% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows latest annual · EPS TTM — · revenue TTM €4.07B · FCF TTM €453.1M (in EUR)
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | 497.2% | -7.8% | -34.7%–1.4% | 100 ↑strong |
| Dividend Yield | 116.4% | 1.1% | 0.2%–2.4% | 99 ↑strong |
| Net Margin | 9.8% | -21.2% | -325.3%–7.2% | 80 ↑strong |
| Operating Margin | 12.8% | -34.5% | -552.0%–8.0% | 82 ↑strong |
| ROE | 9.6% | -36.8% | -92.5%–4.5% | 79 ↑strong |
